Johnson & Johnson Services Inc

Johnson & Johnson Services Inc, established in 1886, stands as a preeminent global healthcare conglomerate specializing in the development of advanced pharmaceuticals and medical technologies. With annual revenue reaching $96.4B, the organization sustains a massive operational scale, supported by a workforce of 10,000-15,000 employees. The company maintains a rigorous focus on high-impact therapeutic areas, including oncology, immunology, neuroscience, and cardiovascular care, consistently delivering innovative medical solutions to healthcare providers and patients across the globe.

The firm’s extensive operational footprint spans 20 distinct locations, facilitating the research, development, and distribution of complex pharmaceuticals and advanced surgical devices. Learn about Johnson & Johnson Services Inc's global headquarters for detailed geographic insights into their primary base in New Brunswick, New Jersey. Their comprehensive product portfolio encompasses critical medical technologies, specialized medicines, and consumer health solutions, reinforcing their status as a dominant leader in the global healthcare market and a key contributor to medical community standards.

Meet Johnson & Johnson Services Inc's team to gain deeper insight into the executive leadership and organizational structure driving their strategic initiatives. The company competes directly with major industry players such as Pfizer, Novartis, Abbott, and Merck, while maintaining a robust market position under the ticker NYSE: JNJ. By prioritizing continuous innovation in medical technology and preventative maintenance, the organization remains committed to improving global health outcomes through its diverse, expansive, and highly integrated product ecosystem.